<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>8(4)</volume><submitter>Takabatake Y</submitter><pubmed_abstract>Pregnancy is associated with a transient increase in risk for breast cancer. However, the mechanism underlying pregnancy-associated breast cancer (PABC) is poorly understood. Here, we identify the protease pappalysin-1 (PAPP-A) as a pregnancy-dependent oncogene. Transgenic expression of PAPP-A in the mouse mammary gland during pregnancy and involution promotes the deposition of collagen. We demonstrate that collagen facilitates the proteolysis of IGFBP-4 and IGFBP-5 by PAPP-A, resulting in increased proliferative signaling during gestation and a delayed involution. However, while studying the effect of lactation, we found that although PAPP-A transgenic mice lactating for an extended period of time do not develop mammary tumors, those that lactate for a short period develop mammary tumors characterized by a tumor-associated collagen signature (TACS-3). Mechanistically, we found that the protective effect of lactation is associated with the expression of inhibitors of PAPP-A, STC1, and STC2. Collectively, these results identify PAPP-A as a pregnancy-dependent oncogene while also showing that extended lactation is protective against PAPP-A-mediated carcinogenesis. Our results offer the first mechanism that explains the link between breast cancer, pregnancy, and breastfeeding.</pubmed_abstract><journal>EMBO molecular medicine</journal><pagination>388-406</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4818749</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer.</pubmed_title><pmcid>PMC4818749</pmcid><pubmed_authors>Germain D</pubmed_authors><pubmed_authors>Keely PJ</pubmed_authors><pubmed_authors>Nagi C</pubmed_authors><pubmed_authors>Jaffer S</pubmed_authors><pubmed_authors>Mandeli J</pubmed_authors><pubmed_authors>Adelson K</pubmed_authors><pubmed_authors>Eliceiri KW</pubmed_authors><pubmed_authors>Takabatake Y</pubmed_authors><pubmed_authors>Oxvig C</pubmed_authors><pubmed_authors>Schmidt H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer.</name><description>Pregnancy is associated with a transient increase in risk for breast cancer. However, the mechanism underlying pregnancy-associated breast cancer (PABC) is poorly understood. Here, we identify the protease pappalysin-1 (PAPP-A) as a pregnancy-dependent oncogene. Transgenic expression of PAPP-A in the mouse mammary gland during pregnancy and involution promotes the deposition of collagen. We demonstrate that collagen facilitates the proteolysis of IGFBP-4 and IGFBP-5 by PAPP-A, resulting in increased proliferative signaling during gestation and a delayed involution. However, while studying the effect of lactation, we found that although PAPP-A transgenic mice lactating for an extended period of time do not develop mammary tumors, those that lactate for a short period develop mammary tumors characterized by a tumor-associated collagen signature (TACS-3). Mechanistically, we found that the protective effect of lactation is associated with the expression of inhibitors of PAPP-A, STC1, and STC2. Collectively, these results identify PAPP-A as a pregnancy-dependent oncogene while also showing that extended lactation is protective against PAPP-A-mediated carcinogenesis. Our results offer the first mechanism that explains the link between breast cancer, pregnancy, and breastfeeding.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2024-11-09T12:22:15.807Z</modification><creation>2019-03-27T03:11:06Z</creation></dates><accession>S-EPMC4818749</accession><cross_references><pubmed>26951623</pubmed><doi>10.15252/emmm.201606273</doi></cross_references></HashMap>